Tick-borne Encephalitis
📧 Sign up to get email alerts when something new happens for Tick-borne Encephalitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years. [Phase 2]
A Phase 2 trial evaluated safety and immunogenicity of two FSME IMMUN NEW vaccinations in healthy children aged 1 to 6 years; the study has …
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223) [Phase 4]
Pfizer reports completion of a Phase 4 follow-up study evaluating antibody persistence and booster vaccination for tick-borne encephalitis.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years [Phase 4]
Pfizer-sponsored Phase 4 study evaluated how long antibodies persist after FSME-IMMUN vaccination and the booster response in adults aged 18…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209) [Phase 4]
Pfizer completed a Phase 4 follow-up study evaluating the persistence of TBE antibody and the need for booster vaccination in children and a…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults [Phase 4]
Phase 4 clinical trial update reporting safety and long-term (up to 5 years) outcomes after a first booster dose of Novartis' Tick-borne enc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE [Phase 4]
This is a completed Phase 4 extension study by Novartis Vaccines to assess how long antibodies against tick-borne encephalitis persist in ch…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination [Phase 4]
Phase 4 study evaluating humoral and cellular immune responses in low- and high-responders after tick-borne encephalitis vaccination. The st…
-
CLINICAL_TRIALS trial_result · 2008-04-23Clinical Trial Update: Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years [Phase 4]
Phase 4 clinical trial update evaluating long-term immunogenicity in children and adolescents five years after boosting with a pediatric tic…
-
CLINICAL_TRIALS trial_result · 2008-03-17Clinical Trial Update: Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children [Phase 4]
A Phase 4 trial evaluating safety, tolerability, and immune response of Tick-borne encephalitis vaccines in healthy children has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-21Clinical Trial Update: Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults [Phase 1]
Phase 1 trial assessing safety and immune response of a Tick-Borne Encephalitis vaccine (LGT(TP21)/DEN4) in healthy adults; study completed …
-
CLINICAL_TRIALS trial_result · 2007-03-13Clinical Trial Update: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults [Phase 4]
Phase 4 update reporting on long-term immunogenicity after boosting with a tick-borne encephalitis vaccine in adults; the study has complete…